Forxiga (dapagliflozin)

pCPA File Number: 20891

Negotiation Status:

Concluded with an LOI

Indication(s):

Diabetes Mellitus, Type 2

Sponsor/Manufacturer:

AstraZeneca Canada Inc.

CDA-AMC Project Number:

SR0428-000

pCPA Engagement Letter Issued:

2016-05-27

Negotiation Process Concluded:

2016-10-03